ArticleBMJ open2026
Strategies to increase medications for opioid use disorder in hospital settings in the USA: protocol for a scoping review.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOpioid use disorder (OUD) remains a serious and life-threatening disease. Medications for opioid use disorder (MOUD) are effective treatments for OUD but a minority of eligible patients receive them. Hospitalisation is an opportune time to increase MOUD use. However, the description of the most successful strategies to implement MOUD is underexplored. This scoping review will methodically review what strategies have been described in the literature to increase MOUD use in hospital settings in the USA. METHODS AND ANALYSIS: Our scoping review will be completed using methods outlined by the ETHICS AND DISSEMINATION: This study does not involve the collection of new data and therefore does not require approval from an institutional review board. We will submit the results of our review to an academic peer-reviewed journal for publication and to relevant stakeholders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.